Zhitong Finance App News, Hengrui Pharmaceutical (01276) issued an announcement. The board of directors announced that it had reviewed and approved the employee stock ownership plan at the board meeting held on August 19, 2026. The employee stock ownership plan is subject to review and approval by the Company's shareholders' meeting before it takes effect.

The company implements this plan with the aim of establishing and improving the benefit-sharing mechanism for the company, shareholders and employees, mobilizing employees' enthusiasm and creativity, improving employee cohesion and corporate competitiveness, and promoting the long-term, sustainable and healthy development of the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.